← Back to patent-cliff list
MC-0518
Tier C — Watch / tradeMC-0518
Medac Gmbh
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Graft-versus-host disease
Regional status
US
-
EU
Phase III
2020-11-16
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of MC-0518?
Approved indications include: Graft-versus-host disease.
When does the MC-0518 patent expire?
No public expiry year is available for MC-0518 yet; this page updates once verified.
How do I get a quote for MC-0518 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06